KATLYN DIAMOND: Open Payments
NPI 1326472788 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 15 payments from 10 companies in 2025. Trend: 2023 $432 · 2024 $374 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $122 |
| AstraZeneca Pharmaceuticals LP | 2 | $66 |
| Novo Nordisk Inc | 2 | $64 |
| Exact Sciences Corporation | 2 | $47 |
| Seqirus USA Inc | 2 | $46 |
| Lilly USA, LLC | 1 | $30 |
| Abbott Laboratories | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Amgen Inc. | 1 | $17 |
Products named: WATCHMAN FLX, Wegovy, Cologuard Collection Kit, JARDIANCE, Flucelvax, FREESTYLE LIBRE 3, REXULTI, CAPVAXIVE.
Industry payments across FL — which companies pay providers there.
